Philux, Immune Checkpoint Inhibitor Theme Rises 29.89% Up

On the 19th, the immuno-oncology theme rose by 3.07% compared to the previous day, showing strength, while Pillux, a related stock attracting attention, surged by 29.89% compared to the previous day. Pillux is known as a company specializing in the manufacture of lighting equipment and components.

[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Pillux's quant financial score is 10.97 points, ranking 11th within the immuno-oncology theme, with higher growth and stability scores than the average of other related stocks. This indicates that compared to other stocks in the theme, Pillux's sales and net income growth rates are relatively fast, and its ability to respond to changes in domestic and international economic environments is also favorable.

[Table] Top Stocks by Financial Score within the Theme

※ The quant financial score is the result of the robo algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.